Home/Filings/4/0000950170-24-025900
4//SEC Filing

LEONARD JOHN M 4

Accession 0000950170-24-025900

CIK 0001652130other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:10 PM ET

Size

7.9 KB

Accession

0000950170-24-025900

Insider Transaction Report

Form 4
Period: 2024-03-01
LEONARD JOHN M
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2024-03-01+113,586960,072 total
  • Award

    Stock Option (right to buy)

    2024-03-01+163,929163,929 total
    Exercise: $32.66Exp: 2034-02-28Common Stock (163,929 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    58,415
Footnotes (3)
  • [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
  • [F2]Shares held by the John M. Leonard 2015 Irrevocable Trust.
  • [F3]This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

Documents

1 file

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1
  • filerCIK 0001563584

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:10 PM ET
Size
7.9 KB